by Andy Rickman | Feb 12, 2018
People who report healthcare companies bribing government doctors or officials may be eligible for a reward under the Dodd-Frank program. Pharma has been bribing doctors by sponsoring and donating to their medical associations and foundations. A key opinion leader or...
by Andy Rickman | Feb 9, 2018
China offers many opportunities for whistleblowers who want to obtain a reward for reporting violations of the Foreign Corrupt Practices Act (FCPA) to the Securities and Exchange Commission (SEC). Much of China’s economy is controlled and operated by either the...
by Andy Rickman | Feb 6, 2018
This is part IV of my FCPA Rewards Pharma Series. Part I of the series can be viewed here, part II of the series can be viewed here, and part III can be viewed here. This video focuses on the pharmaceutical and healthcare sector bribing doctors by hiring and engaging...
by Andy Rickman | Feb 4, 2018
This is first in a series where some of my FCPA whistleblower clients have volunteered to answer a few questions in order to provide insight to future whistleblowers who are considering making a Dodd-Frank reward submission. What is your background? I worked in the...
by Andy Rickman | Feb 1, 2018
This is part III of my FCPA Rewards Pharma Series. Part I of the series can be viewed here, and part II of the series can be viewed here. This video focuses on the pharmaceutical and healthcare sector and will examine reward eligible schemes under the Dodd-Frank...
